These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 10587568)

  • 21. PEGylated interferon alfa-2b and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis.
    Cacoub P; Saadoun D; Limal N; Sene D; Lidove O; Piette JC
    Arthritis Rheum; 2005 Mar; 52(3):911-5. PubMed ID: 15751068
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Scleritis and peripheral ulcerative keratitis with hepatitis C virus-related cryoglobulinemia.
    Kedhar SR; Belair ML; Jun AS; Sulkowski M; Thorne JE
    Arch Ophthalmol; 2007 Jun; 125(6):852-3. PubMed ID: 17563007
    [No Abstract]   [Full Text] [Related]  

  • 23. Cryoglobulinaemia, hepatitis C and interferon therapy.
    Careless D; Sandford N; Tinniswood R; Cobcroft R; Boyle R; Gill D; Hogan P
    Aust N Z J Med; 1993 Aug; 23(4):414-5. PubMed ID: 8240162
    [No Abstract]   [Full Text] [Related]  

  • 24. Cryoglobulinaemia.
    Nat Rev Dis Primers; 2018 Aug; 4(1):12. PubMed ID: 30072792
    [No Abstract]   [Full Text] [Related]  

  • 25. Treatment of hepatitis C-associated mixed cryoglobulinemia vasculitis.
    Saadoun D; Delluc A; Piette JC; Cacoub P
    Curr Opin Rheumatol; 2008 Jan; 20(1):23-8. PubMed ID: 18281853
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dramatic worsening of hepatitis C virus-related cryoglobulinemia subsequent to treatment with interferon alfa.
    Harlé JR; Disdier P; Pelletier J; Azulay JP; Perréard M; Weiller PJ; Jouglard J
    JAMA; 1995 Jul; 274(2):126. PubMed ID: 7595994
    [No Abstract]   [Full Text] [Related]  

  • 27. [Hepatitis C infection with false negative serology in a patient with mixed cryoglobulinemic vasculitis].
    Tini GM; Wüscher V; Jeker R
    Dtsch Med Wochenschr; 2007 Mar; 132(12):616-8. PubMed ID: 17357905
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapy for hepatitis C virus-related cryoglobulinemic vasculitis.
    Dammacco F; Sansonno D
    N Engl J Med; 2013 Sep; 369(11):1035-45. PubMed ID: 24024840
    [No Abstract]   [Full Text] [Related]  

  • 29. Birmingham vasculitis activity score, disease extent index and complement factor C3c reflect disease activity best in hepatitis C virus-associated cryoglobulinemic vasculitis.
    Lamprecht P; Moosig F; Gause A; Herlyn K; Gross WL
    Clin Exp Rheumatol; 2000; 18(3):319-25. PubMed ID: 10895368
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The two-edged sword: vasculitis associated with HIV and hepatitis C coinfection.
    Ojaimi S; Lin MW; Singh KP; Woolley I
    Int J STD AIDS; 2014 Feb; 25(2):77-88. PubMed ID: 23970639
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regression of lymphoproliferative disorder after treatment for hepatitis C virus infection in a patient with partial trisomy 3, Bcl-2 overexpression, and type II cryoglobulinemia.
    Casato M; Mecucci C; Agnello V; Fiorilli M; Knight GB; Matteucci C; Gao L; Kay J
    Blood; 2002 Mar; 99(6):2259-61. PubMed ID: 11877309
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatitis C virus infection and cutaneous vasculitis in mixed cryoglobulinemia.
    La Civita L; Zignego AL; Bernacchi E; Monti M; Fabbri P; Ferri C
    Mayo Clin Proc; 1996 Jan; 71(1):109-10. PubMed ID: 8538224
    [No Abstract]   [Full Text] [Related]  

  • 33. Hepatitis C virus-associated mixed cryoglobulinaemia.
    Dumoulin FL; Spengler U; Sauerbruch T
    Eur J Gastroenterol Hepatol; 1997 Nov; 9(11):1063-5. PubMed ID: 9431895
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatitis C Virus-Associated Cryoglobulinemic Vasculitis.
    Horino T; Ichii O; Inotani S; Matsumoto T; Terada Y
    Am J Med; 2020 Jul; 133(7):e367-e368. PubMed ID: 31926138
    [No Abstract]   [Full Text] [Related]  

  • 35. Interferon therapy in HCV-positive mixed cryoglobulinaemia: viral and host factors contributing to efficacy of the therapy.
    Mazzaro C; Carniello GS; Colle R; Doretto P; Mazzi G; Crovatto M; Santini GF; Tulissi P; Gregoretti M; Mazzoran L; Russo A; Silvestri F; Pozzato G
    Ital J Gastroenterol Hepatol; 1997 Aug; 29(4):343-50. PubMed ID: 9476189
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment for hepatitis C virus-associated mixed cryoglobulinaemia.
    Montero N; Favà A; Rodriguez E; Barrios C; Cruzado JM; Pascual J; Soler MJ
    Cochrane Database Syst Rev; 2018 May; 5(5):CD011403. PubMed ID: 29734473
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cryoglobulinemic vasculitis associated with hepatitis C virus infection. A report of eight cases.
    Revenga Arranz F; Díaz Díaz R; Iglesias Díez L; Cassis Herce B; Sánchez Gómez F; Fuertes Ortiz A
    Acta Derm Venereol; 1995 May; 75(3):234-6. PubMed ID: 7653186
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Hepatitis C virus-associated cryoglobulinemic vasculitis. Physiopathology, diagnosis and therapy].
    Lamprecht P; Schnabel A; Gross WL
    Dtsch Med Wochenschr; 1998 May; 123(20):637-42. PubMed ID: 9627573
    [No Abstract]   [Full Text] [Related]  

  • 39. Hepatitis C virus-associated type II mixed cryoglobulinemia vasculitis complicated with membranous proliferative glomerulonephritis.
    Lo KY; Chen CY; Lee CS
    Ren Fail; 2009; 31(2):149-52. PubMed ID: 19212913
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association between type II cryoglobulinemia and hepatitis C virus in a case treated with interferon-alpha.
    Fukumoto S; Ishimura E; Shoji S; Izumotani T; Kitahashi S; Kuroki T; Nishizawa Y; Morii H
    Nephron; 1996; 73(1):94-6. PubMed ID: 8742965
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.